BioSpace News Archive

Akers Biosciences, Inc., announced that its proposed merger partner MyMD Pharmaceuticals, Inc., a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, has completed the formation of its Scientific Advisory Board.

The American College of Radiology® (ACR®) has brought together the full power of its world-class informatics and clinical research resources to launch the innovative ACR National Clinical Imaging Research Registry™ (ANCIRR™).

Under the ATM Offering, Common Shares will be distributed at trading prices prevailing at the time of the sale.

Quotient Limited, a commercial-stage diagnostics company, announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ™ by Quotient system.

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced it will regain full rights to its narrow spectrum kinase inhibitor (NSKI) portfolio, including PUR1800,

Today, Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, together with its manufacturing partner, has successfully completed the formulation for HT-001, a treatment for cancer patients suffering from cutaneous toxicities (skin, nails, scalp) due to EGFR inhibitor therapies

Company surpasses 11 million COVID-19 vaccines administered, continues to expand access in medically underserved communities

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment of Dmitri Wiederschain, Ph.D., as Chief Scientific Officer.

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring the non-clinical data of PMC-309 at American Association for Cancer Research (AACR) 2021 Annual Meeting taking place virtually.

Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on Monday, May 10 , before the open of the U.S. financial markets. The company also will host a webcast at 10 a.m. ET on May 10 to discuss the results.